Menu

Topics

Connect

Comments

Comments closed.

Due to the sensitive and/or legal subject matter of some of the content on globalnews.ca, we reserve the ability to disable comments from time to time.

Please see our Commenting Policy for more.

COVID-19: FDA panel backs Pfizer booster only for 65+, high-risk Americans

An advisory committee for the U.S. Food and Drug Administration recommended giving booster shots for those aged 65 years and older, as well as those who run a high risk for severe disease. But the panel also shot down a plan to give the extra dose for most Americans aged 16 and older based on data they currently have.

Advertisement

More Videos

Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article